Hippo Signaling Controls NLR Family Pyrin Domain Containing 3 Activation and Governs Immunoregulation of Mesenchymal Stem Cells in Mouse Liver Injury
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The Hippo pathway, an evolutionarily conserved protein kinase cascade, tightly regulates cell growth and survival. Activation of yes‐associated protein (YAP), a downstream effector of the Hippo pathway, has been shown to modulate tissue inflammation. However, it remains unknown as to whether and how the Hippo‐YAP signaling may control NLR family pyrin domain containing 3 (NLRP3) activation in mesenchymal stem cell (MSC)‐mediated immune regulation during liver inflammation. In a mouse model of ischemia/reperfusion (IR)‐induced liver sterile inflammatory injury, we found that adoptive transfer of MSCs reduced hepatocellular damage, shifted macrophage polarization from M1 to M2 phenotype, and diminished inflammatory mediators. MSC treatment reduced mammalian Ste20‐like kinase 1/2 and large tumor suppressor 1 phosphorylation but augmented YAP and β‐catenin expression with increased prostaglandin E2 production in ischemic livers. However, disruption of myeloid YAP or β‐catenin in MSC‐transferred mice exacerbated IR‐triggered liver inflammation, enhanced NLRP3/caspase‐1 activity, and reduced M2 macrophage phenotype. Using MSC/macrophage coculture system, we found that MSCs increased macrophage YAP and β‐catenin nuclear translocation. Importantly, YAP and β‐catenin colocalize in the nucleus while YAP interacts with β‐catenin and regulates its target gene X‐box binding protein 1 (XBP1), leading to reduced NLRP3/caspase‐1 activity after coculture. Moreover, macrophage YAP or β‐catenin deficiency augmented XBP1/NLRP3 while XBP1 deletion diminished NLRP3/caspase‐1 activity. Increasing NLRP3 expression reduced M2 macrophage arginase1 but augmented M1 macrophage inducible nitric oxide synthase expression accompanied by increased interleukin‐1β release. Conclusion: MSCs promote macrophage Hippo pathway, which in turn controls NLRP3 activation through a direct interaction between YAP and β‐catenin and regulates XBP1‐mediated NLRP3 activation, leading to reprograming macrophage polarization toward an anti‐inflammatory M2 phenotype. Moreover, YAP functions as a transcriptional coactivator of β‐catenin in MSC‐mediated immune regulation. Our findings suggest a therapeutic target in MSC‐mediated immunotherapy of liver sterile inflammatory injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Németh, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
Mesenchymal Stem Cell Homing: The Devil Is in the Details
Karp, J. M., & Leng Teo, G. S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.02.001 · Cited by 1,445 · cited 2×
“(2) However, a number of phase III clinical trials of MSC immunotherapy were unable to meet the primary endpoints because of the low immunoregulatory efficacy of engrafted cells.(3) Thus, exploring modulatory mechanisms that govern the immunosuppressive potential of MSC emerges as one of the key challenges of MSC ther…”
BackgroundThe Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Zhao, B., Tumaneng, K., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2303 · Cited by 1,205 · cited 1×
“The Hippo signaling pathway is an evolutionarily conserved pathway that regulates mammalian organ size by controlling cell proliferation, apoptosis, and stem cell self-renewal.(4) Yes-associated protein (YAP), as a key downstream transcriptional coactivator of the Hippo signaling pathway, functions to negatively regul…”
BackgroundYAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response
Azzolin, L., Panciera, T., Soligo, S., Enzo, E., Bicciato, S., Dupont, S., Bresolin, S., Frasson, C., Basso, G., Guzzardo, V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.013 · Cited by 1,094 · cited 1×
“(12,13) Activation of β-catenin regulates cell differentiation and is associated with the HippoYAP pathway(14); YAP may physically interact with β-catenin to regulate tissue homeostasis and regeneration.(15) Although several reports have shown that Hippo signaling can be integrated with other pathways to coordinately…”
BackgroundTLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages
Martinon, F., Chen, X., Lee, A.-H., & Glimcher, L. H. (2010) · Nature Immunology · doi:10.1038/ni.1857 · Cited by 996 · cited 1×
“Indeed, macrophage XBP1 is activated by inositolrequiring enzyme 1 alpha (IRE1α), a stress sensor, which signals innate immunity during inflammatory response.(22) Moreover, activation macrophage IRE1α FIg.”
BackgroundThe Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
Varelas, X. (2014) · Development · doi:10.1242/dev.102376 · Cited by 665
Hypoxia and inflammation are two sides of the same coin
Bartels, K., Grenz, A., & Eltzschig, H. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318345110 · Cited by 218
Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration
Lu, L., Finegold, M. J., & Johnson, R. L. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.205 · Cited by 190
Cited by
Wang, L., & He, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967193 · Cited by 324
Zhou, Y., Liang, Q., Wu, X., Duan, S., Ge, C., Ye, H., Lu, J., Zhu, R., Chen, Y., Meng, F., et al. (2023) · Advanced Materials · doi:10.1002/adma.202210691 · Cited by 115
Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease
Yuan, M., Hu, X., Yao, L., Jiang, Y., & Li, L. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02858-4 · Cited by 89
“showed that BM-MSCs mediate reprogramming of macrophage polarization to an anti-inflammatory M2 phenotype by promoting the Hippo signaling pathway [13].”
BackgroundWang, Y., Cao, C., Zhu, Y., Fan, H., Liu, Q., Liu, Y., Chen, K., Wu, Y., Liang, S., Li, M., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05193-x · Cited by 69
Li, S., Liang, C., Jiang, W., Deng, J., Gu, R., Li, W., Tian, F., Tang, L., & Sun, H. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01610 · Cited by 12
Metadata
- Authors
- Li, C., Jin, Y., Wei, S., Sun, Y., Jiang, L., Zhu, Q., Farmer, D. G., Busuttil, R. W., Kupiec‐Weglinski, J. W., & Ke, B.
- Venue
- Hepatology
- Published
- 2019-06-21
- Volume
- 70
- Issue
- 5
- Pages
- 1714-1731
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2943900681
- Cited by
- 137
- References
- 9
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.